Immunic Inc. (IMUX) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts IMUX Hot Sheet
Join SI Premium – FREE
Immunic Inc. (NASDAQ: IMUX) reported Q3 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- TechCreate Group faces NYSE American delisting proceedings
- PreveCeutical closes second tranche of private placement for $245,000
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
